Lupus Clinical Trials

Showing 1-20 of 3,027 trials

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

NCT07053800

The purpose of this trial is to evaluate the efficacy and safety of obecabtagene autoleucel (obe-cel) administered once following lymphodepletion in participants with severe, refractory systemic lupus erythematosus (SLE) and active lupus nephritis (LN).

Lupus Nephritis

Autolus Limited35 participantsStarted Jan 2026

Syracuse, New York, United States • San Antonio, Texas, United States • Birmingham, United Kingdom +7 more locations

SUSPENDEDPhase 1

Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations

NCT06655649

Obstructive Sleep Apnea (OSA) is a common medical disorder that is associated with reduced quality of life and higher risk of cardiovascular disease. Treatments for OSA and limited and not well tolerated. Our lab has shown that a low carbohydrate, high fat ketogenic diet (KD) can reduce OSA severity. Since it can be challenging to adhere to a ketogenic diet, the investigators propose that ingesting exogenous ketones can be an alternative method to improve OSA. Specifically the investigators will examine the effect of taking a commercially available product (Ketone-IQ) at bedtime on overnight ketones and sleep quality. The investigators will also examine the effect of Ketone-IQ on sleep apnea severity, compared to placebo. This project will examine the pharmacokinetics, tolerability, and sleep impacts of ingesting exogenous ketones before sleep in patients with sleep apnea, while under treatment for OSA. \[Aim 2: Examine the preliminary efficacy of ingesting exogenous ketones before sleep on OSA\]

Obstructive Sleep ApneaSleep

Johns Hopkins University30 participantsStarted Jan 2025

Baltimore, Maryland, United States

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations

Related Searches

A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

Relationship of Exercise, Sleep, and Inflammation Markers in People Living With HIV

Family Study of Affective and Anxiety Spectrum Disorders

Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

Entropy-based Physiological Signal Analysis in Patients With Obstructive Sleep Apnoea

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Non-invasive Ventilation or CPAP in OSA-COPD Following Admission for an Acute Hypercapnic Respiratory Failure

Precision ICU Care: Evaluating an AI-Driven Nursing Decision Support System for Delirium Prevention

Pupillometry in Delayed Sleep Wake Phase Disorder

Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Randomized Clinical Trial for Tonsil Surgery in Adults With Obstructive Sleep Apnea and Enlarged Tonsils

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment

IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)